| Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease (NCT02813265) | Kala Pharmaceuticals, Inc. | 2016-06-01 |
| Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease (NCT02819284) | Kala Pharmaceuticals, Inc. | 2016-06-01 |
| Effects of a Moisturizing Product on Dry Eye and Skin (NCT02683382) | Petra Larmo | 2016-03-01 |
| Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome (NCT02986750) | Medical University of Vienna | 2016-02-13 |
| Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome (NCT02980913) | Medical University of Vienna | 2016-02-11 |
| Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome (NCT02585648) | Medical University of Vienna | 2016-02-01 |
| A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease. (NCT02553772) | Allergan | 2016-01-06 |
| CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) (NCT02617667) | Novaliq GmbH | 2016-01-01 |
| Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye (NCT03183089) | The Mentholatum Company | 2015-12-03 |
| Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD (NCT02621593) | Lumenis Be Ltd. | 2015-10-01 |
| 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients (NCT02595606) | Sun Yat-sen University | 2015-09-01 |
| Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator (NCT02526290) | Oculeve, Inc. | 2015-08-31 |
| Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients (NCT02533154) | Medical University of Vienna | 2015-07-27 |
| Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis® (NCT02554981) | Allergan | 2015-07-21 |
| Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye (NCT02420730) | Allergan | 2015-06-01 |
| Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease (NCT02435914) | Allergan | 2015-06-01 |
| Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation (NCT02385292) | Oculeve, Inc. | 2015-05-31 |
| Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome (NCT02585453) | Medical University of Vienna | 2015-04-01 |
| The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye Disease (NCT02802150) | Chonbuk National University Hospital | 2015-02-01 |
| NovaTears® Eye Drops Observational Study NT-003 (NCT02356328) | Novaliq GmbH | 2015-01-01 |
| NovaTears® Eye Drops Observational Study NT-002 (NCT02356341) | Novaliq GmbH | 2015-01-01 |
| A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief (NCT02455050) | Allergan | 2014-12-01 |
| Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye (NCT02313454) | Allergan | 2014-11-17 |
| A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease (NCT02280473) | Allergan | 2014-11-13 |
| Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms (NCT02851654) | Fondation Ophtalmologique Adolphe de Rothschild | 2014-11-05 |
| A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye. (NCT02205840) | Seikagaku Corporation | 2014-07-01 |
| The Effect of Tear Supplements on Contact Lens Comfort (NCT02956083) | University of the Incarnate Word | 2014-07-01 |
| Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease (NCT02188160) | Kala Pharmaceuticals, Inc. | 2014-06-01 |
| A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye (NCT02117687) | Allergan | 2014-05-14 |
| Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease (NCT02013791) | Allergan | 2014-04-29 |
| Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy (NCT02121847) | Allergan | 2014-04-03 |
| Estrogen and the Outer Eye in Women During Fertility Treatment (NCT02072122) | Meir Medical Center | 2014-03-01 |
| Effects of Sustained Reading on the Ocular Surface (NCT02031172) | University of Rochester | 2014-03-01 |
| Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery (NCT02608489) | Soonchunhyang University Hospital | 2014-01-01 |
| Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes (NCT02461719) | Taejoon Pharmaceutical Co., Ltd. | 2014-01-01 |
| Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease (NCT02229955) | Hanlim Pharm. Co., Ltd. | 2013-12-01 |
| A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN) (NCT02014922) | University of Waterloo | 2013-12-01 |
| A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye (NCT01960010) | Mimetogen Pharmaceuticals USA, Inc. | 2013-10-01 |
| Ocular Surface Microbiome (NCT02298881) | University of Washington | 2013-07-01 |
| A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal (NCT01882413) | Allergan | 2013-06-01 |
| Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye (NCT02403219) | Instituto de Oftalmología Fundación Conde de Valenciana | 2013-05-01 |
| An Observational Study of Dry Eye Prior to Laser-Assisted in Situ Keratomileusis (LASIK) Therapy (NCT01854905) | Allergan | 2013-05-01 |
| Impairment of Reading Ability in Dry Eye Patients (NCT01826812) | Johns Hopkins University | 2013-04-01 |
| A Pilot Study on the Use of a Sensory Panel to Assess Comfort Between Three Different Contact Lenses (NCT01840787) | University of Waterloo | 2013-04-01 |
| A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome (NCT02011776) | Santen Pharmaceutical(China) Co.,LTD | 2013-03-01 |
| Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes (NCT01804361) | DH Bio Co., Ltd. | 2013-03-01 |
| Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis (NCT02252744) | Western University of Health Sciences | 2012-11-01 |
| An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease (NCT01711424) | Allergan | 2012-09-01 |
| Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group (NCT01768312) | Hanlim Pharm. Co., Ltd. | 2012-08-23 |
| Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution (NCT01684852) | Bitop AG | 2012-05-01 |
| A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye (NCT01558999) | Seikagaku Corporation | 2012-03-01 |
| Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome (NCT01568593) | Laboratoires Thea | 2012-03-01 |
| Safety Study of OPC-12759 Ophthalmic Solution (NCT01471093) | Otsuka Pharmaceutical Co., Ltd. | 2011-11-01 |
| Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease (NCT01459588) | Allergan | 2011-10-01 |
| Treatment of Dry Eye With Supplements (NCT01364311) | Medical University of Vienna | 2011-07-01 |
| A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms (NCT02028754) | Allergan | 2011-07-01 |
| Repeatability and Agreement of Anterior Segment Optical Coherence Tomography (AS-OCT) and Thermography (NCT01479790) | Singapore National Eye Centre | 2011-06-01 |
| Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease (NCT01294384) | Allergan | 2011-05-01 |
| Safety Evaluation of a New Preservative in a Lubricating Eye Drop (NCT01434277) | Johnson & Johnson Consumer and Personal Products Worldwide | 2011-04-01 |
| Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers (NCT01278784) | Medical University of Vienna | 2011-03-01 |
| The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients (NCT01280110) | University of Campinas, Brazil | 2011-03-01 |
| Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms (NCT01382810) | Innovative Medical | 2011-03-01 |
| Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye (NCT01319773) | Allergan | 2010-11-01 |
| Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers (NCT01015209) | Medical University of Vienna | 2010-09-01 |
| Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction (NCT01202747) | TearScience, Inc. | 2010-09-01 |
| A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease (NCT01135511) | Pfizer | 2010-07-01 |
| TearLab Refractive Surgery Dry Eye Study (NCT01176045) | TearLab Corporation | 2010-06-01 |
| Dry Eye Assessment and Management: Feasibility Study (NCT01102257) | Asbell, Penny, M.D. | 2010-01-01 |
| Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye (NCT01027013) | Kubota Vision Inc. | 2009-12-01 |
| Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye (NCT00987727) | Allergan | 2009-11-01 |
| Acupuncture for Dry Eye Syndrome (NCT00969280) | Korea Institute of Oriental Medicine | 2009-09-01 |
| Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms (NCT00938704) | Allergan | 2009-06-01 |
| Confirmatory Study of OPC-12759 Ophthalmic Suspension (NCT00885079) | Otsuka Pharmaceutical Co., Ltd. | 2009-05-01 |
| The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye (NCT01268735) | University of Zagreb | 2009-04-01 |
| Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye (NCT00832130) | TearScience, Inc. | 2009-02-01 |
| Long Term Administration Study of OPC-12759 Ophthalmic Suspension (NCT00818324) | Otsuka Pharmaceutical Co., Ltd. | 2009-01-01 |
| Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome (NCT00788229) | Dhp Korea Co., Ltd. | 2008-11-01 |
| A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye. (NCT00784719) | Pfizer | 2008-11-01 |
| Efficacy and Acceptability of Two Lubricant Eye Drops (NCT00756678) | Allergan | 2008-09-01 |
| Comparison of Evaporimetry With the Established Methods of Tear Film Measurement (NCT01496482) | University of Zagreb | 2008-09-01 |
| Effects of Sea Buckthorn Oil on Dry Eye (NCT00739713) | University of Turku | 2008-09-01 |
| Validation of TearLab Osmometer - Human Factor Usability Report (NCT00731484) | TearLab Corporation | 2008-07-01 |
| Diagnostic Evaluation of the Tear Film (NCT00761917) | TearScience, Inc. | 2008-06-01 |
| Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK). (NCT00620893) | Bp Consulting, Inc | 2008-02-01 |
| Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease (NCT01072526) | University of Missouri-Columbia | 2007-12-01 |
| Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients (NCT00611403) | Allergan | 2007-12-01 |
| Late Phase 2 Study of OPC-12759 Ophthalmic Suspension (NCT00475319) | Otsuka Pharmaceutical Co., Ltd. | 2007-05-01 |
| Refractive Surgery and Optive Compatibility Study (NCT00469157) | Innovative Medical | 2007-05-01 |
| Clinical Applications of Advanced Ophthalmic Imaging (NCT03135327) | University of Miami | 2007-01-01 |
| Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus (NCT00797030) | Universidade Federal do Rio de Janeiro | 2006-10-01 |
| The Effect of Punctal Plugs on Tear Volume and Osmolality (NCT00372034) | The University of New South Wales | 2006-07-01 |
| Dose-response Study of OPC-12759 Ophthalmic Suspension (NCT00234078) | Otsuka Pharmaceutical Co., Ltd. | 2005-01-01 |
| Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome (NCT00357201) | Laboratoires Thea | 2004-11-01 |
| Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye (NCT00386646) | Chulalongkorn University | 2004-02-01 |
| A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes (NCT01890941) | Kissei Pharmaceutical Co., Ltd. | |
| Soothe Versus Refresh (NCT00284999) | Pharmaceutical Research Network | |
| A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes (NCT01692145) | Kissei Pharmaceutical Co., Ltd. | |
| A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome (NCT01427816) | Kissei Pharmaceutical Co., Ltd. | |
| Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006) (NCT00549289) | Sirion Therapeutics, Inc. | |
| Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005) (NCT00502073) | Sirion Therapeutics, Inc. | |